You can download the current version of DIQTA 1.0, which has been released on April 20, 2021. The drug-induced QT prolongation (DIQT) classification scheme was developed based on drug labeling information. Furthermore, post-marketing DIQT surveillance data from U.S. Food and Drug Administration (FDA) Spontaneous Adverse Events Reporting System (FAERS) were extracted to represent incidence information of DIQT. In addition, drug properties such as chemical structure, therapeutic categories, and daily dose were also included.